RBC Capital raised the firm’s price target on AdaptHealth (AHCO) to $15 from $13 and keeps an Outperform rating on the shares. The firm is adjusting its model after the company’s Q1 results while also noting that transitory costs and headwinds support accelerated onboarding of new capitated contract, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHCO: